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Urinary oxalate excretion increases with body size and decreases with
increasing dietary calcium intake among healthy adults. Increasing
dietary calcium intake decreases urinary oxalate excretion by increasing
intestinal precipitation of dietary oxalate as calcium oxalate. This mech-
anism was speculated to account for the decreased prospective incidence
of kidney stones as estimated dietary calcium intake, adjusted for caloric
intake, increased among men in a recent large epidemiological study. To
further assess the relationship between estimated diet calcium and urinary
oxalate, we studied 94 healthy adults, 50 women and 44 men, ages 20 to 70
years with weights ranging from 47 to 104 kg while they ate their
customary diets. Each subject completed a semiquantitative food fre-
quency questionnaire and collected three 24-hour urines preserved with
HCI. The urines were collected accurately as judged by a mean intra-
subject CV for creatinine excretion of 9.8% and direct relations between
urinary creatinine excretion and body wt (r = 0.62; P < 0.0001), or
predicted urine creatinine content for sex, age and weight using the
Cockcroft and Gault formulas (r = 0.76; P < 0.0001). Estimated diet
calcium intake ranged from 6.8 to 68 mmol/day (272 to 2720 mg/day) and
averaged 29.5 mmol/day (1180 mg/day). Individual mean urinary oxalate
excretion ranged from 0.079 to 0.332 mmol/day (7 to 29 mg/day) and
averaged 0.198 mmol/day (17 mg/day). Among all subjects, daily oxalate
excretion was directly related to creatinine excretion as an estimate of lean
body mass (r = 0.61; P < 0.0001). Thus, oxalate excretion among men
averaged 0.228 0.051 SD mmol/day, a value significantly higher than the
average among women of 0.173 0.045 mmol/day (P < 0.001). Daily
urine oxalate excretion/creatinine decreased curvilinearly as estimated
dietary Ca intake increased (r =
—0.30; P = 0.0035) and as the ratio of
estimated dietary calcium to dietary oxalate increased (r =
—0.39; P =
0.0001). We conclude that body size is the major determinant of urinary
oxalate excretion among healthy adults, presumably reflecting variations
in endogenous oxalate synthesis with lean body mass. Increasing estimated
diet calcium intake, especially up to the range of 15 to 20 mmol/day (600
to 800 mg/day) has an additional effect to decrease urinary oxalate
excretion, presumably by limiting intestinal absorption of dietary oxalate.
Calcium oxalate is the major component of about 80% of all
kidney stones [1, 21. Average urinary oxalate concentration, as
determined by the daily rate of urinary oxalate excretion relative
to urine volume is, therefore, a critical determinant of the relative
saturation of the urine with respect to poorly soluble calcium
oxalate [3]. Approximately 85% of urinary oxalate is derived from
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oxalate produced in the body as an end product of metabolism,
while the remaining 15% is derived from intestinal absorption of
dietary oxalate [4, 51. Urinary excretion of dietary oxalate is
decreased by increasing dietary calcium intake among both
healthy adults and calcium-stone formers [6—10] because of
precipitation of dietary oxalate with calcium in the gut, thereby
reducing intestinal oxalate absorption. The results of a recent
large epidemiological study demonstrated that the prospective
incidence of kidney stones among 45,000 men without prior stones
decreased over a four year follow-up period as calcium intake,
assessed by a well standardized diet history, increased [111. The
authors of that study proposed that their observations might be
related to a progressive decrease in urinary oxalate excretion, as
dietary calcium intake increased among the participants in the
study as a consequence of the effect of calcium to reduce intestinal
oxalate absorption. The present study was, therefore, primarily
undertaken to directly evaluate urinary oxalate excretion rates
among healthy adults in relation to the composition of their
customary diets, also as assessed by the same diet questionnaire
used in the epidemiological study. Also, since previous studies of
relatively small numbers of stone formers and of healthy subjects
have shown that there appears to be a direct relationship between
daily urinary oxalate excretion and body size [7, 121, we wanted to
extend evaluation of that relationship to a larger group of
subjects.
Methods
We studied 94 healthy adults as out-patients in the Medical
College of Wisconsin Clinical Research Center, with their con-
sent, using a protocol approved by the Medical College of
Wisconsin Human Research Review Committee. Fifty women
and 44 men participated, approximately five women and five men
in each of the ten five-year age intervals between 20 and 70 years.
None had a personal history of kidney stones. Twelve of the 50
women and 1 of the 44 men were regularly taking a calcium
supplement providing  500 mg calcium/day, while 4 of the 50
women and 3 of the 44 men were regularly taking vitamin C  500
mg/day. None was taking diuretics. Each subject was provided a
stipend for the collection of three 24-hour urine specimens and
for the completion of the dietary questionnaire. A semiquantita-
tive food frequency questionnaire was used to evaluate the diets of
the subjects [13—15]. Oxalate-containing foods not on the ques-
tionnaire were added to the list [161 as was the quantity of water
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consumed in addition to other listed beverages. Nutritionist IV
(N-Squared Computing, Salem, OR, USA) software was used to
analyze the nutrient content of the diet for total calories, total
water (water, beverage and water content of foods), oxalate,
protein, calcium, sodium, potassium, fiber and ascorbic acid.
Oxalate values for those foods which have published data were
entered into the software data base.
The urines were preserved with 20 ml of 6 N HCI during
collection to prevent non-enzymatic conversion of ascorbate to
oxalate [12, 17, 18]. Urine volume and the concentrations of
creatinine, oxalate, calcium, magnesium, sodium, potassium, am-
monium, phosphate, citrate, sulfate and urea nitrogen were
measured. Urine volumes were directly measured volumetrically
and were not corrected for the 20 ml of HC1 added to the
collection containers. Creatinine, phosphate, ammonium and urea
nitrogen concentrations were measured using an autoanalyzer by
methods previously described [191. Oxalate was measured using
immobilized oxalate oxidase [20, 21]. During the time period of
the study, the interassay coefficients for low and high oxalate
standards in 18 assays averaged 6.9% and 3.2%, respectively,
while the average recovery of oxalate added to 106 urine speci-
mens averaged 98.0 4.5 SD %. Calcium and magnesium were
measured by atomic absorption spectrophotometry and sodium
and potassium by flame emission spectrophotometry. Sulfate was
measured turbidometrically [22] and citrate using citrate lyase
[23].
Since the urines were collected in HC1 we could not directly
measure urine pH or total C02-content. However, we estimated
urine pH based upon the measured urinary NH4/creatinine ratio
using the mean for that relationship observed in 734 24-hour urine
specimens collected under mineral oil and preserved with thymol
and phenylmercuric nitrate by 42 healthy adults [19, 24, 25]: pH =
6.6965 to 1.6195 * log NH4lcreatinine mmol/mmol; r = 0.78 (pH
range 5.05 to 7.30). Similarly, we estimated urine total CO2
concentration using estimated pH based on the mean relationship
between total CO2 concentrations and pH measured in 631
24-hour urines having a pH ranging from 5.80 to 7.30 from the
same 42 subjects: log [total CO2-content], mmol/liter = —4.8443
+ 0.88814 * pH (r = 0.91). In addition, for urines having a pH <
5.80, we assumed that the urine was in equilibrium with the blood
pCO2 = 40 mm Hg. Since the urines were collected in HC1 we also
could not measure the subject's actual urinary Cl excretion rates.
However, we also assumed that urine [Cl] = urine [Na] since most
Cl is added to foods during preservation, cooking or at table as
NaCI, because dietary Na and Cl in health are almost completely
absorbed by the intestine and because among 145 healthy adults
(86 eating constant diets in our Clinical Research Center provid-
ing < 5 to 275 mmol Na/day and 59 eating their self-selected
home diets) we have observed that: urine Cl mmol/day = 3.77 +
0.946 * urine Na mmol/day (r = 0.97) [25]. Using these derived
data together with the directly measured concentrations of urinary
constituents, we estimated the relative saturation of each urine
with respect to calcium oxalate monohydrate [Ca(COO)2 H2O]
and brushite (CaHPO4 2H20) using the EQUIL program devel-
oped by Finlayson and associates [26].
Results are presented as group means SD and in some
instances ranges. Simple and multiple regression analyses were
performed using SAS. These relationships were considered sig-
nificant if P  0.01. For some analyses dietary intake was adjusted
for caloric intake as described by Willett and associates [13].
Table 1. Subject Characteristics
Women
All Women Men
vs. men
P
Number 94 50 44
Age. years
Mean
Range
43.9
19.8—70.4
44.8
19.8—70.4
42.8
22.2—68.4 0.515
Weight, kg
Mean
Range
72.7
47.3—103.9
66.8
47.3—96.9
79.4
57.0—103.9 <0.001
Height, rn
Mean
Range
1.70
1.52—1.90
1.64
1.52—1.75
1.77
1.61—1.90 <0.001
Surface area, rn2
Mean
Range
1.83
1.44—2.23
1.72
1.44—2.08
1.96
1.70—2.23 <0.001
Body mass index,
kg/rn2
Mean
Range
25.2
18.3—37.1
24.9
18.9—37.1
25.4
18.3—32.0 0.5 13
Group differences between men and women were compared by
unpaired t-test. These comparisons were considered significantly
different if P 0.05. Some additional aspects of the relationships
between measured urine composition and estimated diet compo-
sition will be the subject of separate report.
Results
Subjects
The ages and physical characteristics of all 94 subjects and,
separately, for the 50 women and the 44 men are shown in Table
1. The ages and body mass indices of the women and the men
were similar, but the men, as expected, were heavier, taller and
had larger estimated surface areas.
Daily urine composition
The means and ranges of daily urine composition for all of the
subjects and separately, for the women and the men are shown in
Table 2.
The accuracy of the individual daily urine collections were
evaluated based on their creatinine content in relation to body wt
and to predicted creatinine content based on sex, age and body wt
using the Cockcroft and Gault formulas [27]. The grand mean of
the individual coefficients of variation in creatinine content of the
three urines averaged 9.6%. As shown in Figure 1, creatinine
excretion rates for all urine collections by the 94 subjects was, as
expected, significantly correlated to their body weights; r = 0.62;
P < 0.0001 (Fig. 1A) and more closely correlated to predicted
urinary creatinine content [27] that also takes account of the lower
muscle mass of women and the decline in muscle mass with age;
r = 0.76; P < 0.0001 (Fig. 1B). These data indicate that the
subjects collected their urines with reasonable accuracy.
Despite the larger body size of the men, their mean daily urine
volumes averaged 1587 ml, a value that was slightly less but not
significantly different from the mean of 1685 ml among the
women; P = 0.541 (Table 2). Otherwise, the mean daily urinary
excretion rates of all of the other measured urinary constituents,
with the exception of citrate, were significantly greater among the
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Table 2. Daily urine composition
All 94 subjects 50
Women
44
Men
Women vs. men
PMean Range
Volume mi/day 1645 593—5697 1685 832b 1587 863 0.541
Creatinine mg/day 1462 550—2455 1175 245 1789 285 <0.001
Oxalate mmol/day 0.198 0.079—0.332 0.173 0.045 0.228 0.051 <0.001
Calcium mmoi/day 4.50 1.40—10.88 3.92 1.69 5.16 2.20 0.003
Sodium mmol/day 156 47—322 143 42 171 51 0.006
Potassium mmoi/day 67 24—125 60 18 75 22 <0.001
Magnesium mmol/day 5.85 1.58—10.05 5.24 1.58 6.54 1.66 <0.001
Phosphate mmol/day 29.8 11.9—51.0 25.6 6.7 34.5 7.2 <0.001
Sulfate, mmol/day 20.0 4.0—32.1 17.1 5.5 23.2 4.9 <0.001
Citrate mmol/day 4.12 0.64—9.52 4.40 1.42 3.80 1.42 0.043
Ammonium mmoi/day 32.1 10.9 —74.3 27.3 7.2 37.4 11.9 <0.001
Urea-N g/day 10.15 4.33—19.21 8.84 2.36 11.63 2.68 <0.001
pHa 6.06 5.70—6.53 6.02 0.16 6.11 0.06 0.009
Total CO2 content mmoi/liter' 3.7 1.7—9.3 3.4 1.4 4.1 1.4 0.022
Chloride mmoi/day' 156 47—322 143 42 171 51 0.006
Relative calcium oxalate saturation' 3.1 0.4—8.7 2.5 1.6 3.8 1.6 <0.001
Relative brushite saturation 1.1 <0.1—3.8 0.8 0.8 1.5 0.9 0.001
Estimated as described in Methods
b Variances through the Table are shown as SD.
men, as expected, because of their large body sizes. As shown in
Table 2, the mean daily urinary citrate excretion rate among the
women averaged 4.4 mmol/day (845 mg/day), a quantity signifi-
cantly greater (P = 0.043) than among the men, which averaged
3.8 mmol/day (730 mg/day), as has been observed by others [281.
Mean daily oxalate excretion for all 94 subjects averaged 0.199
0.055 mmol/day (range 0.079 to 0.332 mmol/day). Figure 2
shows that among all 94 subjects mean daily urinary oxalate
excretion rates were directly associated with body wt (r =0.52; P
< 0.0001), with body surface area (r = 0.52; P < 0.0001) and,
more closely, with lean body mass as reflected by mean daily
urinary creatinine excretion (r =0.62;P < 0.0001). Thus, the men,
because of their greater body weight and muscle mass (Table 1
and Fig. 1), excreted an average of 0.228 0.051 mmol oxalate/
day, significantly more than the average oxalate excretion rates
among women that averaged 0.173 0.045 mmol/day (P <
0.000 1).
The urines of the men exhibited relative urinary saturations
with respect to calcium oxalate that were significantly higher than
among the women by about 50% (Table 2) as consequence of: (a)
the greater daily rates of urinary oxalate and calcium excretion
among the men and (b) the same or slightly lower urine volumes
among the men resulting in higher urinary oxalate and calcium
concentrations. Similarly, the average relative saturation of the
urines of the men with respect to brush ite were significantly higher
than those of the women by about 85% (Table 2) because daily
urinary calcium and phosphate excretion rates were significantly
higher, daily urine volumes slightly lower and estimated urine pH
were slightly, but significantly, higher among the men. The urines
of the women were, on average, undersaturated with respect to
brushite.
Estimated diet composition
Table 3 summarizes the means and ranges of estimated diet
composition for the group based on the food frequency question-
naire and, separately, these estimates for women and for men.
The estimates for dietary Ca intake shown in Table 3, which
averaged 26.2 mmol/day and ranged from 6.2 to 65.6 mmol/day,
includes only Ca contained in food and not the additional Ca
taken as supplements by some subjects. When the additional Ca
taken as supplements by some subject was taken into account, Ca
intake for the group averaged 29.5 mmol/day and ranged from 6.8
to 68 mmol/day. Estimated mean daily intakes of total water (in
food, including beverages, as well as water), of oxalate and of
calcium were similar among the men and the women. The
estimated mean daily intakes of potassium among men were
slightly but not significantly greater than among the women
(Table 3). Total vitamin C intake, including that taken as supple-
ments, also did not differ in men and women (Table 3), although
when only vitamin C contained in the basic diets was considered,
the diets of the men were estimated to contain 218 mg vitamin
C/day as compared to 154 mg/day among the women (P =0.011).
The mean daily intakes of the total calories, sodium, phosphate,
and of protein and fiber were significantly greater among the men
than among the women, as expected, because of the larger body
sizes of the men.
Relationships between urinary oxalate excretion and estimated
dietary calcium intake
Figure 3 summarizes the principal observed relationships be-
tween urinary oxalate excretion and dietary Ca intake as well as
the ratio of dietary Ca to dietary oxalate. As shown in Figure 3A,
urinary oxalate excretion, divided by creatinine to take account of
the relationship between oxalate excretion and lean body size
(Fig. 2), was inversely related to the estimated Ca intake of the
basic diet, exclusive of Ca supplements: urine oxalate/creatinine
tmol/mmol = 18.3 to 0.0945 * diet Ca mmol/day (r = —0.27; P =
0.0077). This relationship appeared to be curvilinear: urine ox-
alate/creatinine .tmol/mmol = 24.1 — 6.01 * log(basic diet Ca,
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Fig. 2. Mean daily urine oxalate excretion for each of the 94 subjects in
relation to estimates of body size. A. Mean daily urine oxalate in relation to
body wt: urine oxalate mmol/day = 0.0552 + 0.00197 * weight kg (r =
+ 0.46; P < 0.0001). B. Mean daily urine oxalate in relation to body surface
area: urine oxalate mmol/day = —0.0844 + 0.154 * surface area, m2 (r =
0.52; P < 0.0001). C. Mean daily urine oxalate in relation to mean daily
urine creatinine excretion as an estimate of lean body mass: urine
oxalate mmol/day = 0.0768 + 0.00940 * urine creatinine mmol/day (r
= 0.61; P < 0.0001). In each panel, the right vertical axis gives oxalate
in mass units. In (C) the superior horizontal axis gives creatinine in
mass units.
0
0 5 10 15 20 25
Predicted urine creatinine, mmol/day
(based on sex, age and body weight)
Fig. 1. A. Daily urine creatinine excretion for all 3 urine collections by each
of the 94 subjects in relation to body wt: measured creatinine mmol/day
—0.619 + 0.187 * weight kg (r = 0.62; P < 0.0001). The left vertical axis
gives creatinine in molar units and the right vertical axis gives creatinine in
equivalent mass units. Symbols are: (S) women; (Lx) men. B. Daily urine
creatinine excretion for all urine collections by each subject in relation to
predicted creatinine excretion based on the Cockcroft and Gault formulas:
measured creatinine mmol/day = 2.11 + 0.984 * predicted urine creati-
nine mmol/day (r = 0.76; P < 0.0001). The superior horizontal axis and
right vertical axis give creatinine in mass units.
mmol/day); r =
—0.30; P = 0.0035. Thus, urinary oxalate!
creatinine appeared to decrease to an approximate plateau when
dietary Ca intake exceeded about 20 mmol/day (800 mg/day).
When urinary oxalate/creatinine was evaluated in relation to total
Ca intake that also included the Ca contained in supplements
taken by some of the subjects, an inverse relationship was no
longer detectable (r = —0.10;P = 0.3096). As shown in Figure 3B,
there was a similar trend for urinary oxalate/creatinine to decrease
as the basic dietary Ca intake/kg body wt increased, although
these relationships was not significant: urine oxalate/creatinine
j.tmol/mmol = 17.6 — 4.81 * diet Ca/bodywt mmol/kg (r = —0.20;
P = 0.0458); urine oxalate/creatinine = 13.97 — 3.92 * log(diet
Ca/body wt mmol/kg); r =
—0.20; P = 0,0471. More significantly,
as shown in Figure 3C, urinary oxalate/creatinine was inversely
0 5 10 15 20 25
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Table 3. Daily diet composition
All 94 subjects 50
Women
44
Men
Women vs. men
PMean Range
Water mi/day 2750 1040—5320 2700 880C 2810 890 0.542
Calories kcai/day 2190 780—4530 1936 695 2474 803 0.001
Oxalate mmoi/day
Calcium mmol/dayt'
6.6
26.2
1.3—39.7
6.2—65.6
6.6 3.7
24.7 10.6
6.6 6.5
27.8 12.4
0.985
0.193
Phosphate mmol/day 50 13.7—102 45.4 14.5 55.1 19.4 0.006
Sodium mmoi/day 114 28 —239 102 41 129 47 0.005
Potassium mmol/day 94 37—213 89 25 101 38 0.076
Protein g/day 95 27—206 85 25 106 34 0.00 1
Protein-N glday 15.2 4.3—33.0 13.7 4.0 16.9 5.5
Fiber g/day 22.9 6.9—83.4 20.7 7.6 25.5 14.4 0.041
Vitamin C mg/dajf 262 41—15 12 242 292 286 287 0.465
a Variances throughout the Table are shown as SD
b Estimated calcium in diet; does not include Ca supplements (see text)
Includes vitamin C in supplements
related to the ratio of estimated dietary Ca to dietary oxalate:
urine oxalate/creatinine jxmol/mmol = 17.8 — 0.354 * basic diet
Ca/oxalate mmol/mmol (r =
—0.37; P = 0.0003). This inverse
relationship also appeared to be curvilinear: urine oxalate/creat-
mine mol/mmol = 19.0 — 4.96 * log(diet Ca/oxalate mmol/
rnmol); r =
—0.39; P = 0.0001. Thus, urinary oxalate/creatinine
appeared to decrease to an approximate plateau when the ratio of
dietary Ca/oxalate reached about 5 mmol/mmol or between 2 and
3 mg/mg. When total Ca intake, including the Ca contained in
supplements by some subjects, was used to estimate the dietary
Ca/oxalate ratio, the linear inverse relationship between urinary
oxalate/creatinine and dietary total Ca/oxalate was somewhat less
close: r =
—0.27; P = 0.0089. For all 94 subjects, no significant
relationships could be detected between daily urinary oxalate
excretion and dietary Ca intake, either as estimated basal dietary
Ca intake (P = 0.9906), energy adjusted [13] basal dietary Ca
intake (P = 0.1466), total Ca intake that included the Ca
supplements taken by some subjects (P = 0.6046) or energy
adjusted total Ca intake (P = 0.1519). Similarly, urinary oxalate
excretion divided by creatinine was not related to energy adjusted
basal Ca intake/kg (P = 0.326), total Ca intake/kg (P = 0.7104) or
to energy adjusted total Ca intake/kg (P = 0.7048). There were
trends for urinary oxalate/creatinine to increase as either esti-
mated dietary oxalate intake/kg intake (P = 0.0824) or energy
adjusted dietary oxalate intake/kg increased (P = 0.0454), but
these relationships were not significant.
There were no detectable relationships between individual
mean daily urinary oxalate excretion rates and the estimated daily
intakes of total calories, protein, vitamin C or fiber.
Discussion
Increasing dietary calcium intake as well as the oral adminis-
tration of calcium supplements have been shown to reduce urinary
oxalate excretion rates in healthy subjects and in patients with
calcium kidney stones, due to the precipitation of dietary oxalate
within the intestine thereby limiting intestinal oxalate absorption.
Our observation that urinary oxalate excretion/creatinine declined
as the estimated ratio of dietary calcium to oxalate increased
among healthy adults eating self-selected diets subjects is consis-
tent with those observations.
Several factors may, however, have limited the sensitivity of our
study to assess this relationship. First of all, we have no way of
validating the precision of the estimates of dietary composition
based on the food frequency questionnaire. We did not ask the
subjects who participated in the study to keep dietary diaries on
the day before and the day of each of their urine collections that
could possibly have provided more accurate estimates of their
individual dietary calcium and oxalate intakes. Moreover, the
oxalate content of many foods are not accurately known and, in
addition, the partition of oxalate within a given food between free
oxalic acid that could be precipitated by calcium contained in
other foods and calcium oxalate that presumably would not be so
affected is not well known. Second, previous studies of the effects
of calcium intake on urinary oxalate excretion [6—10] have, almost
exclusively, compared urinary oxalate excretion rates in subjects
eating diets containing 10 mmol Ca/day ( 400 mg Ca/day) to
oxalate excretion rates when dietary calcium intake was  25
mmol/day (1000 mg Ca/day). Only 3 of our 94 subjects living in
Wisconsin, "America's Dairyland," had estimated Ca intakes less
than 10 mmol/day. Moreover, we did not specifically recruit
subjects known to consume diets providing only small amounts of
calcium, nor did we arrange to have a subset of subjects follow a
calcium restricted diet for several weeks before collecting their
urine. We also did not specifically recruit subjects who ate diets
high in oxalate as well as low in calcium that are prevalent among
populations with a high incidence of kidney stones. Thus, the
capacity of the study to detect higher rates of urinary oxalate
excretion when the ratio of dietary Ca to dietary oxalate was low
(<about 2 mmol/mmol) was limited.
When we took account of Ca contained in supplements taken
by some of the subjects of the study, an inverse relationship
between urinary oxalate/creatinine and total dietary Ca intake was
no longer detectable, and the inverse relationship between urinary
oxalate/creatinine and total dietary Ca/oxalate was less close.
Presumably these observations reflect the lesser effects of higher
Ca intakes to reduce urinary oxalate excretion relative to creati-
nine (Fig. 3). It is also possible that some subjects took their Ca
supplements at times separate from meals so that the additional
Ca was not simultaneously available with dietary oxalate to cause
calcium oxalate precipitation in the intestine.
Nevertheless, the results of the present study are consistent with
the results of the epidemiological study that demonstrated that
the prospective incidence of kidney stones among men declined
with increasing dietary Ca intake, an effect attributed to the effect
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Fig. 3. A. Individual mean daily urine oxalate/creatinine excretion in relation
to estimated basic dietaty Ca intake/day (exclusive of Ca supplements): urine
oxalate/creatinine .unol/mmol = 18.3 — 0.0945 * diet Ca mmol/day (r =
—0.27; P = 0.0077); or urine oxalate/creatinine i.unol/mmol 24.1 — 6.0130 * log(diet Ca, mmol/day); r = —0.30; P = 0.0035. B. Individual mean daily' urine oxalate/creatinine excretion in relation to basic dietary Ca intake/
25 day/kg body wt: urine oxalate/creatinine zmol/mmol = 17.6 — 4.81 * diet
Ca/body wt mmol/kg (r = —0.20; P = 0.0458), or urine oxalate/creatinine20 . = 13.97 — 3.92 * log(diet Ca/body wt, mmol/kg); r = —0.20; P = 0.0471.C. Individual mean daily urine oxalate/creatinine excretion in relation to
15 the ratio of individual estimated basal dietary calcium intake to dietary
oxalate intake: urine oxalate/creatinine smol/mmol = 17.8 — 0.354 * diet
Ca/oxalate mmol/mmol (r =
—0.37; P = 0.0003), or urine oxalate/IV
. creatinine zmol/mmol = 19.0 — 4.96 * log(diet Ca/oxalate mmol/mmol);
r =
—0.39; P = 0.0001. In each panel, the inferior horizontal axis and left5 vertical axis give molar units and the superior horizontal axis and right
vertical axis give mass units. Symbols are: (•) women; (A) men.
35 in which mean calcium intake averaged 16.6 mmol/day (664
mg/day). Prospective stone incidence then declined much less
30 steeply to 2.79, 2.66 and 2.43 stones/1000 men/year as mean
calcium intake rose in the three sequentially higher quintiles of
25 intake to means of 19.6 mmol/day (783 mg/day), 23.4 mmol/day
E (937 mg/day) and 33.2 mmol/day (1326 mg/day), respectively. Our20 observations that the urinary oxalate/creatinine ratio decreased in
15 a roughly similar curvilinear manner as dietary Ca or the ratio ofCa to oxalate in the diet increased provides direct support for the
10 . view that increasing dietary Ca, especially increases from very low
to moderate intakes, reduces urinary oxalate excretion and could
5 thereby reduce stone formation. We have compared these results
of the epidemiological study and a comparable analysis of our
data in the three panels of Figure 4. The data suggest that for an
80 kg man excreting 15.9 mmol creatinine/day (1800 mg/day), an
increase in dietary Ca intake from 10 mmol/day (400 mg/day) to
25 mmol/day (1000 mg/day) would reduce oxalate excretion from
about 0.30 mmol/day to about 0.25 mmol/day. This decrement in
35 oxalate excretion as Ca intake is increased by 15 mmol/day is
slightly less than previously estimated decrements of —0.06 to
30
—0.12 mmol/day for an equivalent increase in dietary Ca intake
over the same range [5, 9]. It also should be noted that when
intestinal Ca absorption is enhanced, as occurs among stone-
20 formers with idiopathic hypercalciuria, relatively less Ca would be
available in the intestine to precipitate dietary oxalate. Thus,
15 speculatively, somewhat higher Ca intakes might be necessary
among such patients to minimize absorption of dietary oxalate,
10 . bearing in mind the off-setting effect of a consequent increase in
urinary Ca to increase the relative supersaturation of the urine
5 with respect to calcium oxalate.
Additionally, the results of prospective epidemiological study of
stone incidence in relation to diet composition [11] showed that
stone incidence also fell progressively and essentially linearly as
estimated dietary potassium intake increased and as estimated
fluid intake increased (from 4.3 to 1.8 and from 3.7 to 1.9
stones/100 men/year from the lowest to the highest quintiles of K
and of fluid intake, respectively) in contrast to the apparent near
threshold effect of dietary calcium intake. Whether there may
have been interrelationships between estimates of dietary calcium
intake and intakes of either potassium or fluid in that study is not
fully clear. In the present study, estimates of dietary K and of
dietary fluid were related to estimates of the Ca content of the
basic diet (r = 0.70; P < 0.0001 and r = 0.56; P < 0.0001,
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of increasing dietary Ca to reduce oxalate absorption and thus
urinary oxalate excretion [11]. In that study the prospective
incidence of stones decreased curvilinearly as Ca intake rose, most
strikingly from 4.35 stones/bOO men/year in the lowest quintile of
energy adjusted estimated dietary calcium intake in which mean
calcium intake was 12.9 mmol/day (516 mg/day) to 3.1 stones/1000
men/year in the second quintile of energy adjusted calcium intake
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Fig. 4. Comparison of results of epidemiological study showing a decrease in
prospective stone incidence with increasing dietary Ca intake to data from the
present study. A. Prospective incidence of kidney stones in relation to
means of quintiles of dietary Ca intake. Adapted from data published in
[111. B. Mean urinary oxalate/creatinine in relation to mean of quintiles of
dietary Ca intake in the present study. C. Means of urinary oxalate/
creatinine ratios in relation to quintiles of ratios dietary calcium to dietary
oxalate among the subjects of the present study. For (B) and (C) the
inferior horizontal axis and left vertical axis give molar units and the
superior horizontal axis and right vertical axis give mass units.
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3 urines collected by the 94 healthy adults in relation to daily urine volume (A)
and to urinary oxalate and to urinary calcium Concentrations (B; note log
scale on abscissa). Symbols are: (•) women; (A) men.
respectively). Estimates of fluid intake were significantly related 0.0001). Moreover, urinary volume, mI/kg/day, was related to
to estimates of dietary K intake (r = 0.65; P < 0.0001), and urinary urinary K excretion, mmol/mmol creatinine/day (r = 0.64; P <
volume was also related to urinary K excretion (r = 0.54; P < 0.0001). These relationships suggest a possible interaction of
Lemann et al: Urinaiy oxalate excretion in health 207
increasing dietary intake of water and of K to reduce the incidence
of kidney stones.
Additionally, our observations confirm that increasing daily
urinary oxalate excretion rates among healthy adults are associ-
ated with increasing body weight and with increasing lean body
mass as reflected by daily urinary creatinine excretion. Such a
relationship has been observed previously [7, 12], but has not been
emphasized in studies and in reviews of the role of oxalate in the
formation of calcium oxalate kidney stones. Further studies are
obviously needed to determine whether urinary oxalate excretion
increases with body size among patients with calcium oxalate
kidney stones and whether individuals of large body size are
over-represented among populations of calcium oxalate stone
formers.
Urinary calcium excretion is also well known to increase with
body size and such a trend was again observed in our study: urine
Ca mmol/day = 1.481 + 0.239 * urine creatinine mmol/day (r =
0.42; P < 0.0001). To further explore the importance of these
observations among our healthy subjects, we examined the rela-
tionships between the relative saturation of their urines with
respect to calcium oxalate in relation to urine volume, urinary
calcium concentration and urinary oxalate concentration as illus-
trated in the panels of Figure 5. Most urines from all subjects were
supersaturated with respect to calcium oxalate, thus re-emphasiz-
ing the potential importance of other normal inhibitors of calcium
oxalate crystal nucleation and crystal growth such as osteopontin
(uropontin [31, 321) and nephrocalcin [33] in preventing kidney
stones among healthy adults. At any given urine volume, the
urines of men were relatively more saturated with respect to
calcium oxalate than the urines of women because of the higher
daily rates of oxalate and of calcium excretion (Table 2), and thus
oxalate and calcium concentrations among the men. The relative
saturation of the urines with respect to calcium oxalate rose
progressively as urinary oxalate and calcium concentrations in-
creased (Fig. 5B), and more markedly as the oxalate concentra-
tions increased in comparison to increases in calcium concentra-
tions, as emphasized repeatedly by Finlayson [3]. Presumably,
these features of urine composition, as well as the higher citrate
excretion rates among women, contribute to the well-known
greater incidence of kidney stones in men as compared to women
(men — 3: women 1). Figure 5A also shows the progressively steep
increase in the relative saturation of the urines with respect to
calcium oxalate as daily urine volumes decrease below 1.5 liter/day
among healthy subjects and the decrease in relative calcium
oxalate saturation to a near plateau as urine volumes reach 2.5
liter/day or greater. This observation also re-emphasizes the
importance of greater fluid intakes and thus higher urine volumes
to minimize the relative saturation of the urine with respect to
calcium oxalate.
In summary, our data show that body size is a major determi-
nant of urinary oxalate excretion, and also provide further support
for the view that diets restricted in Ca increase urinary oxalate
excretion. When dietary oxalate varies over ranges generally
consumed in the United States, diets providing 15 to 20 mmol
Ca/day (600 to 800 mg/day) would appear to provide nearly
maximum benefit to reduce urinary oxalate excretion.
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